Barriers to medications for opioid use disorder in the court system: provider availability, provider “trustworthiness,” and cost

por Ahmed, Fatema Z., Andraka-Christou, Barbara, Clark, M.H., Totaram, Rachel, Atkins, Danielle N., del Pozo, Brandon
Publicado 2022

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019

por Andraka-Christou, Barbara, Golan, Olivia, Totaram, Rachel, Ohama, Maggie, Saloner, Brendan, Gordon, Adam J., Stein, Bradley D.
Publicado 2023

A national survey of state laws regarding medications for opioid use disorder in problem-solving courts

por Andraka-Christou, Barbara, Randall-Kosich, Olivia, Golan, Matthew, Totaram, Rachel, Saloner, Brendan, Gordon, Adam J., Stein, Bradley D.
Publicado 2022

Key person-centered care domains for residential substance use disorder treatment facilities: former clients’ perspectives

por Andraka-Christou, Barbara, Atkins, Danielle N., Shields, Morgan C., Golan, Olivia K., Totaram, Rachel, Cortelyou, Kendall, Lambie, Glenn W., Mazurenko, Olena
Publicado 2023

“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs

por Bartholomew, Tyler S., Andraka-Cristou, Barbara, Totaram, Rachel K., Harris, Shana, Doblecki-Lewis, Susanne, Ostrer, Lily, Serota, David P., Forrest, David W., Chueng, Teresa A., Suarez, Edward, Tookes, Hansel E.
Publicado 2022